A Longitudinal (6-week) 3T 1H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression

European Neuropsychopharmacology

Volumn 25, Issue 12, 2015, Pages 2311-2317

  Machado Vieira, Rodrigo ^a,b   Gattaz, Wagner F ^a   Zanetti, Marcus V ^a   De Sousa, Rafael T ^a,b   Carvalho, Andre F ^c   Soeiro de Souza, Marcio G ^a   Leite, Claudia C ^a   Otaduy, Maria C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bipolar disorder; Depression; Glutamate; Imaging; Lithium; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; LITHIUM; N ACETYLASPARTIC ACID; ANTIDEPRESSANT AGENT; GLUTAMINE; LITHIUM DERIVATIVE; PROTON;

ADULT; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MONOTHERAPY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THERAPY EFFECT; TREATMENT DURATION; BIPOLAR DISORDER; CINGULATE GYRUS; DRUG EFFECTS; METABOLISM; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; THREE DIMENSIONAL IMAGING; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; FEMALE; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HUMANS; IMAGING, THREE-DIMENSIONAL; INOSITOL; LITHIUM COMPOUNDS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84952639449     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.08.023     Document Type: Article

References (49)

1. Berridge M.J., Downes C.P., Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989, 59:411-419.
2. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., Cowen P.J. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 2007, 61:806-812.
3. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004, 29:1918-1924.
4. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
5. Colla M., Schubert F., Bubner M., Heidenreich J.O., Bajbouj M., Seifert F., Luborzewski A., Heuser I., Kronenberg G. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol. Psychiatry 2009, 14(696-704):647.
6. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004, 61:450-458.
7. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., McCracken J. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24:359-369.
8. de Sousa R.T., Machado-Vieira R., Zarate C.A., Manji H.K. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin. Ther. Targets 2014, 18:1131-1147.
9. de Sousa R.T., Streck E.L., Zanetti M.V., Ferreira G.K., Diniz B.S., Brunoni A.R., Busatto G.F., Gattaz W.F., Machado-Vieira R. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl). 2015, 232:245-250.
10. de Sousa R.T., van de Bilt M.T., Diniz B.S., Ladeira R.B., Portela L.V., Souza D.O., Forlenza O.V., Gattaz W.F., Machado-Vieira R. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci. Lett. 2011, 494:54-56.
11. de Sousa R.T., Zanetti M.V., Busatto G.F., Mouro M.G., Zarate C.A., Gattaz W.F., Higa E.M., Machado-Vieira R. Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes. J. Psychiatr. Res. 2014, 55:96-100.
12. de Sousa R.T., Zarate C.A., Zanetti M.V., Costa A.C., Talib L.L., Gattaz W.F., Machado-Vieira R. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J. Psychiatr. Res. 2014, 50:36-41.
13. Dickstein D.P., van der Veen J.W., Knopf L., Towbin K.E., Pine D.S., Leibenluft E. Proton magnetic resonance spectroscopy in youth with severe mood dysregulation. Psychiatry Res. 2008, 163:30-39.
14. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008, 13:663-681.
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P) 1995, Biometrics Research, New York State Psychiatry Institute, New York.
16. 1H-magnetic resonance spectroscopy at 1.5 tesla. J. Psychiatr. Res. 1998, 32:411-420.
17. Friedman S.D., Dager S.R., Parow A., Hirashima F., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol. Psychiatry 2004, 56:340-348.
18. Frye M.A., Watzl J., Banakar S., O'Neill J., Mintz J., Davanzo P., Fischer J., Chirichigno J.W., Ventura J., Elman S., Tsuang J., Walot I., Thomas M.A. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007, 32:2490-2499.
19. Gigante A.D., Bond D.J., Lafer B., Lam R.W., Young L.T., Yatham L.N. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012, 14:478-487.
20. Govindaraju V., Young K., Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000, 13:129-153.
21. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 1980, 255:10896-10901.
22. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
23. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 2007, 62:1310-1316.
24. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., Solomon D.A., Leon A.C., Keller M.B. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry 2003, 60:261-269.
25. Kaya N., Resmi H., Ozerdem A., Guner G., Tunca Z. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:521-527.
26. Lyoo I.K., Dager S.R., Kim J.E., Yoon S.J., Friedman S.D., Dunner D.L., Renshaw P.F. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010, 35:1743-1750.
27. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser V., da Silva Vargas R., Kapczinski F., Portela L.V., Souza D.O., Salvador M., Gentil V. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci. Lett. 2007, 421:33-36.
28. Machado-Vieira R., Ibrahim L., Henter I.D., Zarate C.A. Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol. Biochem. Behav. 2012, 100:678-687.
29. Machado-Vieira R., Manji H.K., Zarate C.A. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009, 11(Suppl. 2):S92-S109.
30. Machado-Vieira R., Manji H.K., Zarate C.A. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 2009, 15:525-539.
31. Machado-Vieira R., Soeiro-De-Souza M.G., Richards E.M., Teixeira A.L., Zarate C.A. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J. Biol. Psychiatry 2014, 15:84-95.
32. Machado-Vieira R., Zanetti M.V., DE Sousa R.T., Soeiro-DE-Souza M.G., Moreno R.A., Busatto G.F., Gattaz W.F. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Exp. Ther. Med. 2014, 8:1205-1208.
33. Mattson M.P. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N. Y. Acad. Sci. 2008, 1144:97-112.
34. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., Faulk M.W., Koch S., Glitz D.A., Jolkovsky L., Manji H.K. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol. Psychiatry 2000, 48:1-8.
35. Moore G.J., Bebchuk J.M., Parrish J.K., Faulk M.W., Arfken C.L., Strahl-Bevacqua J., Manji H.K. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am. J. Psychiatry 1999, 156:1902-1908.
36. Moore G.J., Bebchuk J.M., Wilds I.B., Chen G., Manji H.K., Menji H.K. Lithium-induced increase in human brain grey matter. Lancet 2000, 356:1241-1242.
37. Moore G.J., Cortese B.M., Glitz D.A., Zajac-Benitez C., Quiroz J.A., Uhde T.W., Drevets W.C., Manji H.K. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J. Clin. Psychiatry 2009, 70:699-705.
38. Ongür D., Jensen J.E., Prescot A.P., Stork C., Lundy M., Cohen B.M., Renshaw P.F. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol. Psychiatry 2008, 64:718-726.
39. Patel N.C., DelBello M.P., Cecil K.M., Adler C.M., Bryan H.S., Stanford K.E., Strakowski S.M. Lithium treatment effects on Myo-inositol in adolescents with bipolar depression. Biol. Psychiatry 2006, 60:998-1004.
40. Patel N.C., DelBello M.P., Cecil K.M., Stanford K.E., Adler C.M., Strakowski S.M. Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J. Child Adolesc. Psychopharmacol. 2008, 18:132-139.
41. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol. Psychiatry 2003, 54:515-528.
42. Seal R.P., Edwards R.H. Functional implications of neurotransmitter co-release: glutamate and GABA share the load. Curr. Opin. Pharmacol. 2006, 6:114-119.
43. Senaratne R., Milne A.M., MacQueen G.M., Hall G.B. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res. 2009, 172:205-209.
44. Silverstone P.H., McGrath B.M., Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord. 2005, 7:1-10.
45. Soeiro-de-Souza M.G., Salvadore G., Moreno R.A., Otaduy M.C., Chaim K.T., Gattaz W.F., Zarate C.A., Machado-Vieira R. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 2013, 38:468-475.
46. Yatham L.N., Kennedy S.H., Parikh S.V., Schaffer A., Beaulieu S., Alda M., O'Donovan C., Macqueen G., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Milev R., Bond D.J., Frey B.N., Goldstein B.I., Lafer B., Birmaher B., Ha K., Nolen W.A., Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013, 15:1-44.
47. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
48. Zarate C., Machado-Vieira R., Henter I., Ibrahim L., Diazgranados N., Salvadore G. Glutamatergic modulators: the future of treating mood disorders?. Harv. Rev. Psychiatry 2010, 18:293-303.
49. Zanetti, M.V., Otaduy, M.C., de Sousa, R.T., Gattaz, W.F., Busatto, G.F., Leite, C.C., Machado-Vieira R., 2014. Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study. Int J Neuropsychopharmacol. 18, (6).